Whole-genome microarray gene expression profiling has rapidly become the gold standard platform for retrospective prognostic and predictive gene discovery in human cancers, but currently depends ...

While microarray technology is broadening its applications in genomics and proteomics, the technique remains a vibrant contributor in the area of gene expression. Much of the overall developmental ...

Those include Affymetrix-type oligonucleotide microarray chips, DNA-based microarrays, quantitative RT-PCR, and serial analysis of gene expression (SAGE). Contract Research ...

Affymetrix Inc. has announced the full commercial launch of the GeneChip® Human Gene 1.0 ST Array, the latest addition to its whole-transcript assay-based gene expression product family. The ...

The FDA clears Affymetrix Gene Profiling Reagents as gene expression accessories to its GeneChip® Microarray Instrument System for IVD use, becomes fi ...

Microarray analyses cost as little as $100 per sample for standard gene-expression analysis and $300 per sample for more-complex analyses involving differentiation between variant splice forms, ...

We determined the gene-expression profiles in samples of peripheral blood or bone marrow from 285 patients with AML using Affymetrix U133A GeneChips containing approximately 13,000 unique genes or ...

The kit efficiently generates sufficient target from as little as 20 ng of FFPE-derived total RNA for complete gene expression profiling applications such as biomarker discovery and validation.

Affymetrix Inc. announced that the US Food and Drug Administration (FDA) has granted regulatory clearance to its GCS3000Dx (GCSDx) platform for in vitro gene expression diagnostic testing. The ...